일차성 단일증상성 야뇨증 환아에서 소변내로의 요칼슘배설에 대한 연구

정우영,조민현,박용훈,대한 소아배뇨장애야뇨증학회,Chung, Woo-Yeong,Cho, Min-Hyun,Park, Yong-Hoon 대한소아신장학회 2011 Childhood kidney diseases Vol.15 No.2

목적 : 야간다뇨증과 요실금을 가진 아동에서 고칼슘뇨증이 원인적 요인의 하나로 관여할 수 있다는 보고가 있으며, 일부 연구자들은 야뇨증을 가진 아동들을 진단함에 있어서 소변내로의 칼슘배설의 정도를 측정할 것을 권유하였다. 그러나 다른 연구자들은 야뇨증과 소변내로의 칼슘배설 사이에 의미있는 연관성을 입증하지 못했다. 이에 저자들은 일차성 단일증상성 야뇨증을 가진 환아들을 대상으로 소변내로의 칼슘 배설을 측정하여 야뇨증과의 관련성을 조사하였다. 방법:야뇨증으로 처음 진단 받은 5세 이상의 환자 36명을 대상으로 하였다. 혈장 칼슘농도를 측정하였으며, 단회뇨를 이용한 소변검사를 통해서 소변 삼투압, Na, 요소 및 Ca/Cr 농도비를 동시에 측정하였다. 24시간 소변의 채집은 오전 8시부터-오후 8시, 오후 8시부터-다음날 오전 8시로 두 번에 나누어 채집하였으며 각각의 소변 20-40 mL를 이용하여 삼투압과 Ca/Cr농도 비를 산출하였다. 고칼슘뇨증의 정의는 야뇨증 진단 당시에 주간(오전 8시-오후 8시)과 야간(오후 8시-오전 8시)으로 나누어 채집한 단회성 소변검사상에서 칼슘/크레아티닌 비가>0.2 이상이면서 24시간뇨 검사상 칼슘의 배설량이 ${\geq}4mg/kg$ 이상인 경우로 정의하였다. 결과: 36명의 환자 중에서 고칼슘뇨증에 해당하는 경우는 6명으로 16.7%의 빈도를 보였다. 고칼슘 뇨군에서의 단회뇨를 이용한 칼슘/크레아티닌 비는 주간뇨 검사에서는 $0.23{\pm}0.10$, 야간뇨 검사에서는 $0.33{\pm}0.10$로 야간뇨 검사에서 높았으나, 통계적인 유의성은 없었다. 24시간뇨 검사상의 평균 칼슘 배설량은 체중 (kg)당 8.95 mg이었다. 혈청 칼슘 농도와 주간/야간 소변량의 비도 고칼슘뇨군과 정상 칼슘군 사이에서 차이가 없었다. 또한 소변의 osmolality, Na 농도, 요소 농도 등도 양군사이에 유의한 차이가 없었다. 또한 주간이나 야간에 채집된 뇨에서 각각의 해당 기간 동안의 소변량과 칼슘/크레아티닌 비 그리고 칼슘/크레아티닌 비와 요중 Na농도, 요소농도, osmolality 간에는 유의한 상관관계는 없었다. 결론 : 야뇨증 환자의 일부에서 관찰되는 고칼슘 뇨증이 야간 다뇨에 의한 일차성 단일증상성 야뇨증의 직접적인 원인이 아니라고 생각한다. Purpose : Hypercalciuria has been suggested to be involved in the pathogenesis of nocturnal enuresis associated with polyuria. We have measured the amount of calcium excretion in the urine from children with monosymptomatic nocturnal enuresis and studied the association with enuresis. Methods : Thirty-six children (20 males and 16 females, age 5 to 15.6 years) presenting with monosymptomatic nocturnal enuresis were recruited for this study. Results : Among 36 patients, 6 patients had hypercalciuria, providing a 16.7% frequency. The mean Ca/Cr ratio of hypercalciuria group showed $0.23{\pm}0.10$ on daytime, and $0.33{\pm}0.10$ on nighttime showing higher values in nighttime, but it was not statistically significant. Average 24 hour calcium excretion was 8.95 mg/kg. Night/day time urine volume ratio in hypercalciuria group was $0.87{\pm}0.20$, and that in normocalciuria group was $0.81{\pm}0.33$, also showing no difference. Daytime Ca/Cr ratio and nighttime Ca/Cr ratio from all enuresis patients showed a significant correlation (P=0.0001). However, Ca/Cr ratio between daytime and nighttime urine volume had no significant correlation, respectively (daytime P=0.08; nighttime P=0.07). Also, daytime and nighttime Na concentration, urea concentration, and osmolality also had no significant correlation with urine Ca/Cr ratio, respectively. Conclusion: Hypercalciuria shown in some of enuresis patients is not directly caused by primary monosymptomatic nocturnal enuresis.

이미프라민과 데스모프레신이 야뇨증 환자에서 수면 중 각성에 미치는 영향에 대한 다기관연구

김준모,남궁미경,박관현,박용훈,이상돈,이승주,정재용,대한야뇨증학회,김영식 대한비뇨의학회 2008 Investigative and Clinical Urology Vol.49 No.2

Purpose: We performed a multicenter, prospective study to evaluate the efficacy of imipramine and desmopressin to improve arousability and prevent nocturnal enuresis(NE). Materials and Methods: The total of 48 children with NE were given questionnaires that included a scoring system for the assessing arousal from sleep. They were assigned into two groups: group 1(imipramine 25 mg, 3 girls and 16 boys, mean age 7.9 years), group 2(desmopressin 0.2 mg, 9 girls and 9 boys, mean age 7.5 years). The assessment of arousability was repeated 2 weeks and 4 weeks after medication. Eleven children were excluded because of incomplete data. Results: Mean wetting events in group 1 decreased from 8.8 to 5.1 times(2 weeks) and 3.0 times(4 weeks)(p=0.009) versus 10.2 to 5.5 times(2 weeks) and 6.4 times(4 weeks)(p=0.007) for group 2. The mean threshold of arousability in group 1 was 4.9(baseline), 4.4(2 weeks), and 3.7(4 weeks), and, for group 2, 5.1(baseline), 4.8(2 weeks), and 4.8(4 weeks). The two groups were not different(p=0.14, p=0.73). Conclusions: Imipramine and desmopressin, which are commonly used in treating NE in Korea, influenced wetting events but not arousability. (Korean J Urol 2008;49:168-173) Purpose: We performed a multicenter, prospective study to evaluate the efficacy of imipramine and desmopressin to improve arousability and prevent nocturnal enuresis(NE). Materials and Methods: The total of 48 children with NE were given questionnaires that included a scoring system for the assessing arousal from sleep. They were assigned into two groups: group 1(imipramine 25 mg, 3 girls and 16 boys, mean age 7.9 years), group 2(desmopressin 0.2 mg, 9 girls and 9 boys, mean age 7.5 years). The assessment of arousability was repeated 2 weeks and 4 weeks after medication. Eleven children were excluded because of incomplete data. Results: Mean wetting events in group 1 decreased from 8.8 to 5.1 times(2 weeks) and 3.0 times(4 weeks)(p=0.009) versus 10.2 to 5.5 times(2 weeks) and 6.4 times(4 weeks)(p=0.007) for group 2. The mean threshold of arousability in group 1 was 4.9(baseline), 4.4(2 weeks), and 3.7(4 weeks), and, for group 2, 5.1(baseline), 4.8(2 weeks), and 4.8(4 weeks). The two groups were not different(p=0.14, p=0.73). Conclusions: Imipramine and desmopressin, which are commonly used in treating NE in Korea, influenced wetting events but not arousability. (Korean J Urol 2008;49:168-173)

국내 소아에서의 과민성방광 유병률 및 위험인자: 정의에 따른 비교분석

정재민,이상돈,강동일,권동득,김건석,김수영,김한권,문두건,박관현,박용훈,배기수,서홍진,이정원,조원열,하태선,한상원,조병만,대한야뇨증학회 대한비뇨의학회 2008 Investigative and Clinical Urology Vol.49 No.12

Purpose: We wanted to estimate the prevalence and risk factors of overactive bladder(OAB) in Korean children who were 5-13 years of age, according to the definition of OAB. Materials and Methods: A randomly selected cross-sectional study was conducted on 26 kindergartens and 27 elementary schools nationwide in Korea. There were 19,240 children; a parent was asked to complete the questionnaires, which included items about OAB and the children’s voiding and defecating habits. OAB was defined as urgency with or without urge incontinence, and usually with an increased daytime frequency and nocturia(ICCS 2006, group A) or an increased daytime frequency(>8 times/day) and/or urge urinary incontinence with or without urgency (group B); its prevalence and associated factors were investigated. Results: The response rate for the questionnaires was 85.84%. The overall prevalence of OAB was 16.59%(group A) and 18.79%(group B). For groups A and B, the prevalence of OAB decreased with age from 22.89% to 12.16% and from 40.44% to 9.60%, respectively(p=0.0001). The overall rate of wet and dry OAB was 26.97% and 73.03%, respectively. Compared to the normal group, the children with OAB had a higher prevalence of nocturnal enuresis(NE), constipation, fecal incontinence, a history of urinary tract infection and delayed bladder control in both groups A and B(p<0.05). The rate of increased daytime frequency and urge incontinence were 3.69% and 2.31%(p=0.009), and 26.97% and 14.78%(p=0.0001) in group A and for the non-OAB children, respectively; their prevalence in group A decreased with age from 5.04% to 3.06% and from 45.74% to 18.50%, respectively(p=0.0001). Conclusions: The overall prevalence of OAB in group A for Korean children 5-13 years of age was similar to that in group B. However, the range of prevalence in group B was much more variable than that in group A. NE, constipation, fecal incontinence, a history of urinary tract infection and delayed bladder control may be risk factors for OAB in children.